wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36416358-002E9B41-08B3-4C68-918A-97FCC9BBEF29
Q36416358-002E9B41-08B3-4C68-918A-97FCC9BBEF29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36416358-002E9B41-08B3-4C68-918A-97FCC9BBEF29
Is targeted therapy feasible in acute myelogenous leukemia?
P2860
Q36416358-002E9B41-08B3-4C68-918A-97FCC9BBEF29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36416358-002E9B41-08B3-4C68-918A-97FCC9BBEF29
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d7874d294f3b61e692976429851a422bea1ee4c4
P2860
Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3.